To access this element change to forms mode OFF
Grant Award View - GA217931
A Randomised Controlled Trial of MDMA-Assisted Psychotherapy for...
GA ID:
GA217931
Agency:
Department of Health and Aged Care
Approval Date:
4-Nov-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$3,762,327.90
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
A Randomised Controlled Trial of MDMA-Assisted Psychotherapy for Treatment-Resistant Social Anxiety in Young Adults with Autism Spectrum Disorder
Purpose:
Social anxiety is common in young adults with autism. It compounds the core symptoms of autism, contributing to disability and distress. Current treatments are often ineffective. MDMA-assisted psychotherapy is a novel treatment shown to be safe and possibly effective in a pilot study. We propose a clinical trial of MDMA-assisted psychotherapy for treatment-resistant social anxiety in young adults with autism. Results may provide an efficacious new treatment option for this disabling condition.
GO ID:
GO Title:
MRFF - Clinical Trials Activity Initiative - 2021 Innovative Therapies for Mental Illness - Grant Opportunity
InternalReferenceId:
2021/MRF2010957
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC
Postcode:
Multiple
Country:
AUSTRALIA